Janssen Healthcare Innovation (Johnson & Johnson)
Marco is Partner of Janssen Healthcare Innovation (Johnson & Johnson) in Europe, Middle East and Africa (EMEA).
Janssen Healthcare Innovation (JHI) was established in 2010 by the Pharmaceutical Global Operating Committee with the vision to accelerate the transformation of J&J from a product-centric company to a broader health care company. JHI has the specific mission to identify, foster and manage a portfolio of transformational partnerships; accelerate the development, experimentation and learning from new ideas and business models that will lead to new revenue streams; as well as drive collaboration within J&J and the industry and enable the creation of new healthcare markets.
Prior to taking on this role, Marco was heading up the Neuroscience Business Unit and Member of the Management Committee of Janssen (Pharmaceutical Companies of Johnson & Johnson) in the UK.
Before joining Janssen as Strategic Marketing Director in the EMEA in 2007, Marco was Principal at the strategy consultancy Monitor Group, where he advised numerous clients in the life science sector on a wide range of strategic and operational issues.